Free Trial
ASX:VRT

Virtus Health (VRT) Stock Price, News & Analysis

Virtus Health logo

About Virtus Health Stock (ASX:VRT)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
339,634 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
2.96%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Virtus Health Limited provides various healthcare services in Australia, Denmark, the United Kingdom, Ireland, and Singapore. The company operates through two segments, Healthcare Services Australia and Healthcare Services International. It provides fertility services, medical day procedure services, and medical diagnostics and pathology services. It also offers in-vitro fertilization (IVF) services. In addition, the company offers medical day procedure services, such as gastroenterologists, colorectal surgeons, plastic surgeons, urologists, gynecologists, ophthalmologists, dental surgeons, hand surgeons, and other surgeons. As of August 23, 2021, it operated through a network of 128 fertility specialists supported by approximately 1300 professional staff. Virtus Health Limited was founded in 2008 and is headquartered in Greenwich, Australia.

Receive VRT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Virtus Health and its competitors with MarketBeat's FREE daily newsletter.

VRT Stock News Headlines

Virtus KAR Health Sciences C
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
VRT Quantitative Stock Analysis
Virtus Tactical Allocation A
Virtus KAR Small-Cap Growth C
See More Headlines

VRT Stock Analysis - Frequently Asked Questions

Virtus Health Limited (ASX:VRT) posted its quarterly earnings results on Tuesday, February, 19th. The company reported $0.18 EPS for the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that Virtus Health investors own include Revvity (PKI), Gray Television (GTN), (NESCQ) (NESCQ), Teradyne (TER), AbbVie (ABBV), Aphria (APHA) and AquaBounty Technologies (AQB).

Company Calendar

Last Earnings
2/19/2019
Today
5/28/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Medical Care
Sub-Industry
Electronic Equipment
Current Symbol
ASX:VRT
CIK
N/A
Fax
N/A
Employees
27,000
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
11.91
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$335.40 million
Price / Cash Flow
20.38
Book Value
A$3.96 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (ASX:VRT) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners